Vitale, D.L.; Caon, I.; Parnigoni, A.; Sevic, I.; Spinelli, F.M.; Icardi, A.; Passi, A.; Vigetti, D.; Alaniz, L.
Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells. Biomolecules 2021, 11, 246.
https://doi.org/10.3390/biom11020246
AMA Style
Vitale DL, Caon I, Parnigoni A, Sevic I, Spinelli FM, Icardi A, Passi A, Vigetti D, Alaniz L.
Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells. Biomolecules. 2021; 11(2):246.
https://doi.org/10.3390/biom11020246
Chicago/Turabian Style
Vitale, Daiana L., Ilaria Caon, Arianna Parnigoni, Ina Sevic, Fiorella M. Spinelli, Antonella Icardi, Alberto Passi, Davide Vigetti, and Laura Alaniz.
2021. "Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells" Biomolecules 11, no. 2: 246.
https://doi.org/10.3390/biom11020246
APA Style
Vitale, D. L., Caon, I., Parnigoni, A., Sevic, I., Spinelli, F. M., Icardi, A., Passi, A., Vigetti, D., & Alaniz, L.
(2021). Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells. Biomolecules, 11(2), 246.
https://doi.org/10.3390/biom11020246
